Design of New Daunorubicin Derivatives with High Cytotoxic Potential
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26031270 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Aleksandra A Kalashnikova und 14 weiteren Autor:innen. Beteiligte Einrichtung: Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Vavilova St. 28, Bld. 1, Moscow 119991, Russia. Hauptthemen laut MEDLINE: Daunorubicin, Drug Design, Antineoplastic Agents, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Non-Profit Joint-Stock Company "Korkyt Ata Kyzylorda University", Non-Profit Joint-Stock Company “Korkyt Ata Kyzylorda University”.
Abstract (Originalsprache)
Chemotherapy with anthracycline antibiotics is a common method of treating tumors of various etiologies. To create more highly effective cytostatics based on daunorubicin, we used the method of reductive amination using polyalkoxybenzaldehydes. The obtained derivatives of the anthracycline structure have much greater cytotoxicity compared to daunorubicin due to increased affinity for DNA, the ability to disrupt the cell cycle, and their inhibition of the glycolysis process, which is confirmed by data from extensive biological studies and the results of molecular modeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Vavilova St. 28, Bld. 1, Moscow 119991, Russia.
- Laboratory of Engineering Profile, Korkyt Ata Kyzylorda University, Ayteke bi Str., 29A, Kyzylorda 120014, Kazakhstan.
- Institute of Physiologically Active Compounds of the FSBIS of the Federal Research Center for Problems of Chemical Physics and Medicinal Chemistry of the RAS, 1 Severnyi Proezd, Chernogolovka 142432, Russia.
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, Moscow 119991, Russia.
- Department of Biology, Geography and Chemistry, Laboratory of Engineering Profile, Korkyt Ata Kyzylorda University, Ayteke bi Str., 29A, Kyzylorda 120014, Kazakhstan.
- Laboratory of Engineering Profile, Department of Engineering Technology, Korkyt Ata Kyzylorda University, Ayteke bi Str., 29A, Kyzylorda 120014, Kazakhstan.
ORCID-Profile: Anastasiya A Globa, Eugene V Radchenko, Vladimir A Palyulin, Yulia R Aleksandrova, Nurbol O Appazov, Vladimir N Chubarev, Margarita E Neganova
Förderung
- the Non-Profit Joint-Stock Company "Korkyt Ata Kyzylorda University"
- Non-Profit Joint-Stock Company “Korkyt Ata Kyzylorda University”
Zitieren
APA
Kalashnikova, A. A., Toibazarova, A. B., Artyushin, O. I., Anikina, L. V., Globa, A. A., Klemenkova, Z. S., Andreev, M. V., Radchenko, E. V., Palyulin, V. A., Aleksandrova, Y. R., Syzdykbayev, M. I., Appazov, N. O., Chubarev, V. N., Neganova, M. E., & Brel, V. K. (2025). Design of New Daunorubicin Derivatives with High Cytotoxic Potential. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031270
Vancouver
Kalashnikova AA, Toibazarova AB, Artyushin OI, Anikina LV, Globa AA, Klemenkova ZS, et al. Design of New Daunorubicin Derivatives with High Cytotoxic Potential. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031270
BibTeX
@article{Kalashnikova2025,
author = {Kalashnikova, Aleksandra A and Toibazarova, Altynkul B and Artyushin, Oleg I and Anikina, Lada V and Globa, Anastasiya A and Klemenkova, Zinaida S and Andreev, Maxim V and Radchenko, Eugene V and Palyulin, Vladimir A and Aleksandrova, Yulia R and Syzdykbayev, Marat I and Appazov, Nurbol O and Chubarev, Vladimir N and Neganova, Margarita E and Brel, Valery K},
title = {Design of New Daunorubicin Derivatives with High Cytotoxic Potential},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031270}
}
EUVIMED